
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
TIMP-1 CRISPR/Cas9 KO Plasmid (h) | sc-400408 | 20 µg | $397.00 |
TIMP1 encodes tissue inhibitor of metalloproteinases-1 (TIMP-1), a secreted glycoprotein that binds and inhibits matrix metalloproteinases to regulate extracellular matrix turnover and proteolytic signaling. By constraining MMP activity, TIMP-1 influences cell–matrix interactions, tissue remodeling, and inflammatory responses, with downstream effects on migration, invasion, and cytokine-driven remodeling programs. TIMP-1 is also implicated in MMP-independent signaling through cell-surface interactions that can modulate survival and proliferation pathways in a context-dependent manner. Altered TIMP1 expression and TIMP-1/MMP balance are frequently studied in fibrosis, arthritis, cardiovascular remodeling, and cancer biology, where dysregulated matrix dynamics contribute to disease-associated phenotypes.
TIMP-1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the TIMP1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the TIMP1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the TIMP1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish TIMP-1 protein expression.
This CRISPR knockout system enables efficient generation of TIMP1-deficient cell models for investigation of TIMP-1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.